Pfizer, Inc shot up over 3 percent on Tuesday after printing its first-quarter earnings before the market open.
The pharmaceutical giant reported adjusted earnings per share of $1.62, which beat the consensus estimate of $1.50. Pfizer reported sales of $25.70 billion, beating the $23.95 billion estimate. $13.2 billion of Pfizer’s sales came from its COVID-19 vaccine.
